Free Trial

Cetera Investment Advisers Purchases 28,046 Shares of The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Key Points

  • Cetera Investment Advisers increased its stake in The Clorox Company by 49.5%, owning 84,738 shares valued at approximately $12,478,000 after purchasing 28,046 additional shares.
  • Clorox reported a quarterly earnings miss with an EPS of $1.45, falling short of analysts' estimates of $1.57, and its revenue declined by 8.0% compared to the previous year.
  • Several hedge funds have adjusted their positions in Clorox, with institutional investors currently holding about 78.53% of the company's stock.
  • Want stock alerts on Clorox? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Cetera Investment Advisers increased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 49.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 84,738 shares of the company's stock after acquiring an additional 28,046 shares during the quarter. Cetera Investment Advisers owned about 0.07% of Clorox worth $12,478,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. American Century Companies Inc. raised its holdings in Clorox by 17.9% in the fourth quarter. American Century Companies Inc. now owns 76,400 shares of the company's stock worth $12,408,000 after purchasing an additional 11,606 shares in the last quarter. Blair William & Co. IL raised its holdings in Clorox by 1.2% in the fourth quarter. Blair William & Co. IL now owns 9,271 shares of the company's stock worth $1,506,000 after purchasing an additional 107 shares in the last quarter. Pictet Asset Management Holding SA raised its holdings in Clorox by 2.5% in the fourth quarter. Pictet Asset Management Holding SA now owns 74,605 shares of the company's stock worth $12,117,000 after purchasing an additional 1,787 shares in the last quarter. Allstate Corp bought a new position in Clorox in the fourth quarter worth $605,000. Finally, California Public Employees Retirement System raised its holdings in Clorox by 1.3% in the fourth quarter. California Public Employees Retirement System now owns 565,810 shares of the company's stock worth $91,893,000 after purchasing an additional 6,987 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CLX shares. Jefferies Financial Group reduced their price target on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Wells Fargo & Company raised their price target on Clorox from $135.00 to $138.00 and gave the company an "equal weight" rating in a report on Friday. Evercore ISI set a $140.00 price target on Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Citigroup restated a "neutral" rating and set a $135.00 price target (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Finally, Barclays reduced their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $143.36.

View Our Latest Analysis on Clorox

Insider Activity

In other news, Director Pierre R. Breber purchased 4,000 shares of the business's stock in a transaction on Wednesday, May 7th. The stock was acquired at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director directly owned 4,000 shares in the company, valued at $546,280. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Stock Performance

NYSE CLX traded down $2.50 during trading hours on Friday, hitting $123.06. The company's stock had a trading volume of 3,928,421 shares, compared to its average volume of 1,666,065. The Clorox Company has a 12 month low of $117.35 and a 12 month high of $171.37. The company's 50 day simple moving average is $126.07 and its two-hundred day simple moving average is $139.01. The company has a market cap of $15.17 billion, a P/E ratio of 18.87, a price-to-earnings-growth ratio of 3.46 and a beta of 0.49. The company has a debt-to-equity ratio of 13.07, a current ratio of 0.74 and a quick ratio of 0.44.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 538.72% and a net margin of 11.40%. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. During the same period last year, the company earned $1.82 EPS. Clorox's revenue for the quarter was up 4.5% on a year-over-year basis. As a group, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be paid a dividend of $1.24 per share. The ex-dividend date is Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. This is an increase from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is presently 76.07%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines